Goldman Sachs’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.8K | Buy |
|
|||||
|
2025
Q1 | $64.7K | Sell |
|
|||||
|
2024
Q4 | $350K | Buy |
|
|||||
|
2024
Q3 | $196K | Buy |
|
|||||
|
2024
Q2 | $99.3K | Sell |
|
|||||
|
2024
Q1 | $1.47M | Buy |
|
|||||
|
2023
Q4 | $61K | Buy |
|
|||||
|
2023
Q3 | $54.1K | Sell |
|
|||||
|
2023
Q2 | $649K | Buy |
|
|||||
|
2023
Q1 | $72.6K | Buy |
|
|||||
|
2022
Q4 | $54.6K | Sell |
|
|||||
|
2022
Q3 | $95K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $48K | Buy |
|
|||||
|
2021
Q3 | $55K | Sell |
|
|||||
|
2021
Q2 | $351K | Sell |
|
|||||
|
2021
Q1 | $715K | Buy |
|
|||||
|
2020
Q4 | $360K | Buy |
|
|||||
|
2020
Q3 | $348K | Buy |
|
|||||
|
2020
Q2 | $294K | Buy |
|
|||||
|
2020
Q1 | $142K | Sell |
|
|||||
|
2019
Q4 | $205K | Buy |
|
|||||
|
2019
Q3 | $189K | Sell |
|
|||||
|
2019
Q2 | $480K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $54K | Buy |
|